Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Estrogen in Metastatic Breast Cancer
NCT00131924Phase 2Terminated
- Sponsor
- Northwestern University
- Start
- Mar 2004
- Primary completion
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of esterified estrogens in breast cancer, sponsored by Northwestern University. Primary endpoint: Clinical Response Rate. Started Mar 2004; status: terminated.
02
Drugs
esterified estrogens
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00131924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00131924.